Cite
HARVARD Citation
Frangoul, H. et al. (2021). CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Obstetrical & gynecological survey. 76 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Frangoul, H. et al. (2021). CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Obstetrical & gynecological survey. 76 (6), p. . [Online].